MedElevator Войти в исследования
← Поиск публикаций

DOI 10.55563/clinexprheumatol/hbadoz

Медицинская библиотека · Clinical and experimental rheumatology · 2021

The association of different serum IgG4 levels with distinct clinical characteristics and treatment efficacy in patients with IgG4-related disease.

Zhang Panpan, Liu Zheng, Li Jieqiong, Fei Yunyun, Wang Xiaorong, Wang Mu, Zhu Liang, Xue Huadan, Feng Ruie, Hu Chaojun, Zhang Shulan, Zhang Wen, Zhao Yan, Zeng Xiaofeng, Zhang Fengchun

СтатьяПеревод в очереди

Аннотация

OBJECTIVSE: To explore the clinical characteristics and treatment efficacy of IgG4-related disease (IgG4-RD) patients with different levels of serum IgG4.

METHODS

A total of 299 patients newly diagnosed with IgG4-RD were enrolled in this study. Patients were classified into four groups according to baseline serum IgG4 levels: Group A: normal concentration; Group B: > normal but <2× the upper reference limit (URL); Group C: between 2× and 5× the URL; Group D: >5× the URL. All patients were followed up for 12 months. The patients' clinical characteristics, laboratory parameters, plasmablasts/plasma cells and treatment efficacy were analysed.

RESULTS

IgG4-RD patients with higher serum IgG4 levels had higher percentages of dacryoadenitis, sialadenitis, and autoimmune pancreatitis and a higher prevalence of allergy history, whereas patients with retroperitoneum and mediastinum lesions usually had lower serum IgG4 levels. In addition, the serum IgG4 re-elevation rate in Group D (19.4%) was higher than those in Group B (4.9%) and Group C (7.7%) (p=0.003 and p=0.020, respectively). Patients suffered fewer clinical relapses with a serum IgG4 reduction ≥50% of baseline serum IgG4 in Group B and ≥40% of baseline serum IgG4 in Group D (p=0.019 and p=0.043, respectively). In addition, the rate of clinical relapse in patients who received combination therapy with glucocorticoids and mycophenolate mofetil was 18.75% in Group D, which was higher than the rates in Groups B and C (0) (p=0.027).

CONCLUSIONS

IgG4-RD patients with different levels of serum IgG4 exhibit different clinical characteristics and treatment responses.

Для цитирования: Zhang Panpan, Liu Zheng, Li Jieqiong, Fei Yunyun, Wang Xiaorong, Wang Mu, Zhu Liang, Xue Huadan, Feng Ruie, Hu Chaojun, Zhang Shulan, Zhang Wen, Zhao Yan, Zeng Xiaofeng, Zhang Fengchun. The association of different serum IgG4 levels with distinct clinical characteristics and treatment efficacy in patients with IgG4-related disease.. Clinical and experimental rheumatology. 2021. DOI: 10.55563/clinexprheumatol/hbadoz.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.